By reducing the number of LDL receptors (LDLR) on the surface of liver cells, PCSK9 leads to the accumulation of LDL-C, increasing the risk of CVDs
The investigators reported improvements in skin density, dermal thickness, laxity (firmness), and reduction of fine lines in the GHK-Cu arm compared with vehicle control over the 12-week treatment period [3]
These modifications regulate various aspects of target proteins, including their activity, stability, interactions with other proteins, and intracellular localization [34]
For example, KCC2 showed good diagnostic accuracy (AUC = 0.844) with 75% sensitivity and 100% specificity
Patients with a personal or familial history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, severe gastrointestinal illnesses, or pancreatitis history, should not pursue Zepbound
(PubMed) Herbert V